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Abstract
Introduction: Previously undiagnosed glucose-6-phosphate dehydrogenase (G6PD) deficiency
can be unmasked by a diabetic crisis and both can be associated with rhabdomyolysis. The
relationship between diabetes and G6PD deficiency is discussed and the possible triggers for
haemolysis as outlined in this case report. The incidence of G6PD deficiency is 10% in African-
American males and up to 35% in parts of Africa so an increased awareness of G6PD deficiency is
important when treating diabetes in these populations.
Case presentation: A 54-year-old Kenyan man presented with a 3-day history of reduced
appetite, weakness and reduced level of consciousness as a result of a hyperglycaemic diabetic crisis
with both hyperosmolarity and ketoacidosis. The patient then developed haemolysis and a raised
creatine kinase level. A diagnosis of G6PD deficiency and rhabdomyolysis was made.
Conclusion: This case highlights the importance of simple laboratory investigations in the early
identification of the rarer complications of diabetic crisis such as haemolysis secondary to G6PD
deficiency and rhabdomyolysis.
Introduction
The acute hyperglycaemic complications of diabetes
include diabetic ketoacidosis (DKA) and hyperosmolar
nonketotic syndrome (HONK). Both are potentially life-
threatening and complications include: ischaemia or inf-
arction affecting any organ, particularly myocardial or cer-
ebral; thromboembolic disease; acute respiratory distress
syndrome; disseminated intravascular coagulation; multi-
organ failure; rhabdomyolysis; cerebral oedema (rare in
adults, less so in children); and iatrogenic complications
due to inexpert rehydration and electrolyte management,
over-administration of insulin or fluid overload leading
to cardiac failure. Mortality from HONK is high, with
reported death rates as high as 30% to 35%. HONK is the
first manifestation of type 2 diabetes in about one-third of
cases.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
is an X-linked inherited disorder that increases the vulner-
ability of erythrocytes to oxidative stress and is the most
common enzyme deficiency worldwide and usually
affects persons of African, Asian, Mediterranean or Mid-
dle-Eastern descent. Different gene mutations cause differ-
ent levels of enzyme deficiency, with classes assigned to
various degrees of deficiency and disease manifestation.
The two most common mutations are G6PD Mediterra-
nean and G6PD African. For example, 10% of black males
in the United States have moderate (10% to 60% of nor-
mal) enzyme activity. Complications include acute
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haemolysis and neonatal jaundice. This case demon-
strates several complications that can occur with a new
presentation of diabetes mellitus and highlights the
importance of simple laboratory investigations including
tests for methaemoglobinaemia and creatine kinase in the
early identification of G6PD deficiency and rhabdomyol-
ysis.
Case presentation
A 54-year-old Kenyan man presented with a 3-day history
of reduced appetite, weakness and reduced level of con-
sciousness. There was no history of diabetes. On examina-
tion, blood pressure was 99/48 mmHg, pulse 121 beats
per minute, respiratory rate 32 breaths per minute and
temperature 37.5°C with a Glasgow Coma Score of 10/
15. Laboratory investigations revealed: pH 7.172; 1+ uri-
nary ketones; glucose 83.4 mmol/l (1502 mg/dl); HbA1c
5.6%; sodium 152 mmol/l; potassium 4.5 mmol/l; creat-
inine 384 μmol/l (4.34 mg/dl); urea 25 mmol/l (70 mg/
dl); C-reactive protein (CRP) <5.0 mg/l; haemoglobin
18.6 g/dl; and white blood cell count 15.08 × 109/litre.
Initially the patient was treated as diabetic ketoacidosis
with intravenous insulin at a rate of 6 U/hour with 0.9%
saline. Later, the plasma osmolality was calculated as 422
mmol/l and the diagnosis revised to diabetes mellitus
with hyperosmolarity and acidosis. The rate of intrave-
nous insulin was reduced to 3 U/hour and intravenous
fluids changed to alternate 5% dextrose and 0.9% saline.
Despite this, the next day the patient deteriorated further
with quadriparesis, loss of speech and dysphagia and was
transferred to a high-dependency unit with a presumed
diagnosis of central pontine myelinolysis. Over the next 2
days plasma electrolytes and renal function normalised
but CRP increased to 350 mg/l and ceftriaxone and met-
ronidazole were started for presumed aspiration pneumo-
nia. Clinically the patient improved and began speaking
and eating. MRI scanning showed no evidence of pontine
changes. After 3 days the patient was returned to the ward
and the regimen was converted to oral gliclazide 160 mg
BD.
The next day he became unwell again with an oxygen sat-
uration on pulse oximetry of 85% that did not alter with
the concentration of inspired oxygen, and with discol-
oured urine and muscle weakness. Despite the pulse oxi-
metry reading, arterial blood gas showed a pO2 of 18.3
kPa but with a methaemoglobin level of 7.8%. Laboratory
investigations revealed: bilirubin 48 μmol/l; phosphate
0.25 mmol/l; haemoglobin 7.6 g/dl; platelets 206 × 109/
litre. In view of the dropping haemoglobin and discol-
oured urine, a haemolysis screen and a creatine kinase
level measurement were performed, which revealed the
following results: LDH 3392 IU/l; haptoglobin 0.2 g/l;
absolute reticulocyte count 345.6 × 109/litre; negative
direct antiglobulin test negative; and creatine kinase
51,800 IU/l (Figure 1). In the presence of the haemolysis
and methaemoglobinaemia, G6PD and pyruvate kinase
assays were performed. A diagnosis of G6PD deficiency
3.9 IU/gHb (5.2 to 11.5) and low pyruvate kinase 10.2 IU/
gHb (11 to 19) was made. Rhabdomyolysis was also diag-
nosed. Retrospective creatine kinase levels were measured,
which showed that it had been raised to a lesser degree
earlier during his period of limb weakness (Figure 1D).
His phosphate level was also low throughout this period
but his renal function had remained within the normal
range (Additional file 1).
The patient was treated with supportive blood transfu-
sions and all medication was stopped apart from the intra-
venous insulin and intravenous fluids. His haemoglobin
increased, reticulocytes count rose and serum creatine
kinase and bilirubin returned to normal (Figure 1) and he
was discharged home on subcutaneous insulin.
Discussion
We describe a case of a new presentation of diabetes with
both hyperosmolarity and ketoacidosis. Hyperosmolality
and ketoacidosis occurs in approximately 30% of diabetic
hyperglycaemic emergencies. Well-recognised complica-
tions include cerebral oedema, adult respiratory distress
syndrome and vascular thrombosis, but this case illus-
trates two rarer complications: haemolysis and rhab-
domyolysis.
The diabetic emergency revealed that this patient had pre-
viously undiagnosed G6PD deficiency. It was possible to
diagnose G6PD deficiency by identifying it as a cause of
both haemolysis and methaemoglobinaemia [1]. In a
G6PD-deficient subject, haemolysis may occur as a result
of ingestion of various drugs, infection and, more specifi-
cally, among diabetic subjects as a result of hypoglycae-
mia[2], blood glucose normalisation [3], ketoacidosis in
the African[4,5] but not Mediterranean variant [6], and
following administration of metformin [7] or glibencla-
mide [8]. The precipitant of the haemolysis is not clear in
this case and may have involved a combination of infec-
tion, gliclazide and ketoacidosis.
It has been observed that defects in the G6PD gene corre-
late with diabetes and a more recent study proposed that
alterations in genes controlling both insulin secretion and
G6PD-mediated antioxidant defences may contribute to a
predisposition to diabetes [9].
This patient also developed rhabdomyolysis. Very high
glucose levels, high osmolality and low phosphate levels,
which are all recognised risk factors for developing rhab-
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Laboratory investigations during the 22 days of admission Figure 1
Laboratory investigations during the 22 days of admission. Normal values are shown by the grey lines. (A) Haemoglobin; (B) 
absolute reticulocyte count; (C) bilirubin; (D) creatine kinase.
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Summary of key learning points Figure 2
Summary of key learning points. This case has raised several important considerations when managing patients with G6PD defi-
ciency and diabetes.
 Learning points 
Testing for G6PD deficiency should be considered in children and adults 
(especially males of African, Mediterranean, or Asian descent) when a diagnosis 
of diabetes is made 
In a G6PD-deficient diabetic patient, haemolysis may occur as a result 
hypoglycaemia, blood glucose normalization, ketoacidosis, glibenclamide, 
metformin  
Methaemoglobinaemia can be used to aid diagnosis of G6PD-deficency 
There may be an increased incidence of diabetes in G6PD deficient individuals 
Rhabdomyolysis can occur especially in the presence of very high glucose and 
low phosphate levels and high plasma osmolality  
Serum creatine kinase level can be used to detect rhabdomyolysis Publish with BioMed Central    and   every 
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interesting to consider that G6PD muscle cell deficiency
may also contribute to rhabdomyolysis [10].
Conclusion
We have reported the case of a patient presenting with a
diabetic crisis with hyperosmolarity and acidosis, which
was complicated by haemolysis secondary to G6PD defi-
ciency and rhabdomyolysis. This case highlights the
importance of simple laboratory investigations, such as
methaemoglobinaemia and serial measurements of creat-
ine kinase (Figure 2), to detect these complications.
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Renal function during the 22 days of admission. Renal function as dem-
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